Browsing Category
Pharmatrans Sanaq
DiCom SANAQ® SP204 – Co-processed excipient suitable for acid sensitive API’s
PHARMATRANS SANAQ offers excipients and active ingredients of outstanding quality and performance. With our research & development skill and tradition, we commit to study innovative technological solutions providing excipients contributing successfully to smart and efficient pharmaceutical…
Read More...
Read More...
Review on Starter Pellets: Inert and Functional Cores
A significant proportion of pharmaceuticals are now considered multiparticulate systems. Modified-release drug delivery formulations can be designed with engineering precision, and patient-centric dosing can be accomplished relatively easily using multi-unit systems. In many cases, Multiple-Unit…
Read More...
Read More...
Incorporation of itraconazole nano-co-crystals into multiparticulate oral dosage forms
Limited research has been performed on the downstream processing of nano-co-crystal suspensions into solid oral dosage forms. The objectives of this study were to evaluate the impact of three downstream processes (wet granulation, spray granulation and bead layering) on the performance of…
Read More...
Read More...
Influence of In Situ Calcium Pectinate Coating on Metoprolol Tartrate Pellets for Controlled Release…
In situ calcium pectinate-coated pellets were proposed by applying an alternate coating method to drug-layered pellets to achieve colon-specific drug delivery. Solution layering of metroprolol tartrate, a water-soluble model drug, on inert core pellets was achieved using a centrifugal granulator…
Read More...
Read More...
Integrated Purification and Formulation of an Active Pharmaceutical Ingredient via Agitated Bed…
Integrated API and drug product processing enable molecules with high clinical efficacy but poor physicochemical characteristics to be commercialized by direct co-processing with excipients to produce advanced multicomponent intermediates. Furthermore, developing isolation-free frameworks would…
Read More...
Read More...
Pharmatrans SANAQ® introduces easily soluble CBD powder
Pharmatrans SANAQ® has added to its range of ingredients and excipients an easily soluble and high
purity powder containing between two and six per cent cannabidiol (CBD) as a flavorless
intermediate for food, feed, or cosmetics.
The end result is an easy-to-mix powder suitable for immediate…
Read More...
Read More...
Pharmatrans SANAQ® DC customized solutions for DiCOM SANAQ® direct compression applications
Pharmatrans SANAQ® offers a wide range of tailored and customized excipients for solid dosage forms tailored for direct compression (DiCOM) manufacturing processes.
These solutions help overcome a series of industry challenges, such as production difficulties, supply problems, and manufacturing…
Read More...
Read More...
Pharmatrans specific functional starter cores for improved bioavailability and dissolution
Pharmatrans Sanaq specialized range of pharmaceutical excipients and novel drug vehicles includes pellets to aid design of various types of solid dosage forms.
The range has been extended from standard types of microcrystalline cellulose, such as neutral starter cores CELLETS®, purely made of…
Read More...
Read More...
Prediction of quality attributes (mechanical strength, disintegration behavior and drug release) of…
High shear wet granulation is commonly applied technique for commercial manufacturing of tablets. Granulation process for tablets manufacturing is generally optimized by hit and trial which involves preparation of granules under different processing parameters, compression of granules and evaluation…
Read More...
Read More...
Pharmatrans SANAQ® Sugar Spheres and MCC pellet excipients for controlled release
Recent trends have emphasised that multi-particulate drug delivery systems are especially suitable for achieving controlled or delayed release oral formulations with low risk of dose dumping, flexibility of blending to attain different release patterns as well as reproducible and short gastric…
Read More...
Read More...